Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets October 29, 2022 | Yhaoo!
July 29, 2022 | The Malta Independent An Israeli medical cannabis company, Panaxia, has announced a €6 million investment and is set to deepen its connection with
May 19, 2022 | Yahoo! Finance Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the
April 5, 2022 | BENZINGA – Net Israeli revenues in 2021 increased 38% to 83.6 million. – Initial revenues from medical cannabis oils export from Israel, which
January 3, 2022 | BENZINGA Panaxia Global (TASE: PNAX), which owns medical cannabis company Panaxia Labs Israel Ltd., has obtained official authorization from the EU Health Authority for the EU-GMP standard
December 15, 2021 | I24NEWS i24NEWSDecember 15, 2021, 08:58 PM latest revision December 15, 2021, 08:59 PM i24NEWSAnchor Jeff Smith (R) and Dr. Dadi Segal, Panaxia
December 8, 2021 | BENZINGA Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales
November 29, 2021 | Yahoo! The company resumed double-digit growth following a decrease in Q2 due to divesting its distribution and logistics operations. Revenues in the
November 3, 2021 | Yahoo! This week, the first export of medical cannabis extracts for inhalation left Israel to Germany, the largest and fastest-growing medical cannabis
September 2, 2021 | Yahoo! In the cumulative first six months of 2021, the company executed retail sales in Germany and Cyprus; Revenues of the 2nd